We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 1AMGN market cap is 159.25B. The company's latest EPS is USD 7.6135 and P/E is 40.24.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 25.42B | 25.98B | 26.32B | 28.19B | 33.42B |
| Operating Income | 9.14B | 7.64B | 9.67B | 9.38B | 7.57B |
| Net Income | 7.26B | 5.89B | 6.55B | 6.72B | 4.09B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.95B | 61.17B | 65.12B | 97.15B | 91.84B |
| Total Liabilities | 53.54B | 54.47B | 61.46B | 90.92B | 85.96B |
| Total Equity | 9.41B | 6.7B | 3.66B | 6.23B | 5.88B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10.5B | 9.26B | 9.72B | 8.47B | 11.49B |
| Investing | -5.4B | 733M | -6.04B | -26.2B | -1.05B |
| Financing | -4.87B | -8.27B | -4.04B | 21.05B | -9.42B |
| Market Cap | 159.25B |
| Price to Earnings Ratio | 40.24 |
| Price to Sales Ratio | 4.92 |
| Price to Cash Ratio | 13.75 |
| Price to Book Ratio | 28.01 |
| Dividend Yield | 3.36% |
| Shares Outstanding | 537.2M |
| Average Volume (1 week) | 92 |
| Average Volume (1 Month) | 82 |
| 52 Week Change | 11.70% |
| 52 Week High | 337.65 |
| 52 Week Low | 244.55 |
| Spread (Intraday) | 3.75 (1.26%) |
| Company Name | Amgen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.amgen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
